๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer

โœ Scribed by Dimitrios N. Melegos; Eleftherios P. Diamandis


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
578 KB
Volume
29
Category
Article
ISSN
0009-9120

No coin nor oath required. For personal study only.

โœฆ Synopsis


Objectives:

To examine the diagnostic value of prostate-specific antigen (psa) subfractions in the serum of female breast cancer patients.

Design and methods:

Psa subfractions (free psa, f-psa; psa bound to alpha 1-antichymotrypsin, psa-act) were determined in the serum of patients with breast cancer and in the serum of healthy women. serum was injected into a high-performance liquid chromatography column and all fractions were analyzed for psa using a highly sensitive psa immunofluorometric assay. we studied 3 normal male sera, 3 sera from prostate cancer patients who underwent radical prostatectomy (all for comparative purposes), 3 sera from healthy women, 3 sera from women with breast cancer obtained presurgically, and 7 sera from women with breast cancer, postsurgically.

Results:

All male sera contained mostly psa-act complexes and very little free psa. sera from all healthy women also contained mostly psa-act complexes and nondetectable or traces of free psa. all 3 presurgical sera from patients with breast cancer contained predominantly free psa. patients who had surgical resection of the breast tumor and were in remission had postsurgical serum psa subfractions similar to those of healthy women (i.e., mostly psa-act complexes).

Conclusion:

The serum psa subfractions of breast cancer patients are substantially different from serum psa subfractions of male patients, healthy females, and females who have apparently been treated successfully for breast cancer. these findings may form the basis for a serological diagnostic test for breast cancer.


๐Ÿ“œ SIMILAR VOLUMES


Prostate specific antigen molecular form
โœ Gudrun H. Borchert; He Yu; George Tomlinson; Maurizia Giai; Riccardo Roagna; Ric ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 2 views

We have analyzed matched serum and breast cyst fluid samples for total PSA from 148 patients with fibrocystic breast disease. We have also determined the molecular forms of PSA (free PSA and PSA bound to a 1 -antichymotrypsin) in 78 breast cyst fluid samples. We found that total PSA can be detected

Molecular forms of prostate-specific ant
โœ Klaus Jung; Carsten Stephan; Ulrike Elgeti; Michael Lein; Brigitte Brux; Glen Kr ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 149 KB ๐Ÿ‘ 1 views

Molecular forms of prostate-specific antigen (PSA) improve the differentiation between benign prostatic hyperplasia (BPH) and prostate cancer (PCa) in men with total PSA concentrations between 4 and 10 microg/l. To evaluate the diagnostic utility of free PSA (fPSA) and complexed PSA forms for identi

Immunoreactivity of prostate-specific an
โœ Raj K. Gupta ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB ๐Ÿ‘ 3 views

Prostatic-specific antigen (PSA) is regarded as a specific marker secreted by normal and neoplastic acinar epithelial cells of the prostate gland; its detection by immunocytochemistry has been accepted as an indication of metastatic prostate cancer. This is ascribed to the commonly held belief that

The fall and rise of prostate-specific a
โœ Gunar K. Zagars; Alan Pollack ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 890 KB

Background. The serum kinetics of prostate-specific antigen (PSA) after radiation therapy for prostate cancer are not well characterized, and the potential prognostic significance of serum half-lives and of serum doubling times is unclear. This study was designed to address those issues. Methods. O